Interaction of Acyl-CoA Binding Protein (ACBP) on Processes for Which Acyl-CoA is a Substrate, Product or Inhibitor
Overview
Authors
Affiliations
It is shown that acyl-CoA binding protein (ACBP), in contrast with fatty acid binding protein (FABP), stimulates the synthesis of long-chain acyl-CoA esters by mitochondria. ACBP effectively opposes the product feedback inhibition of the long-chain acyl-CoA synthetase by sequestration of the synthesized acyl-CoA esters. Feedback inhibition of microsomal long-chain acyl-CoA synthesis could not be observed, due to the formation of small acyl-CoA binding vesicles during preparation and/or incubation. Microsomal membrane preparations are therefore unsuitable for studying feedback inhibition of long-chain acyl-CoA synthesis. ACBP was found to have a strong attenuating effect on the long-chain acyl-CoA inhibition of both acetyl-CoA carboxylase and mitochondrial adenine nucleotide translocase. Both processes were unaffected by the presence of long-chain acyl-CoA esters when the ratio of long-chain acyl-CoA to ACBP was below 1, independent of the acyl-CoA concentration used. It is therefore not the acyl-CoA concentration as such which is important from a regulatory point of view, but the ratio of acyl-CoA to ACBP. The cytosolic ratio of long-chain acyl-CoA to ACBP was shown to be well below 1 in the liver of fed rats. ACBP could compete with the triacylglycerol-synthesizing pathway, but not with the phospholipid-synthesizing enzymes, for acyl-CoA esters. Furthermore, in contrast with FABP, ACBP was able to protect long-chain acyl-CoA esters against hydrolysis by microsomal acyl-CoA hydrolases. The results suggest that long-chain acyl-CoA esters synthesized for either triacylglycerol synthesis or beta-oxidation have to pass through the acyl-CoA/ACBP pool before utilization. This means that acyl-CoA synthesized by microsomal or mitochondrial synthetases is uniformly available in the cell. It is suggested that ACBP has a duel function in (1) creating a cytosolic pool of acyl-CoA protected against acyl-CoA hydrolases, and (2) protecting vital cellular processes from being affected by long-chain acyl-CoA esters.
ACBP/DBI neutralization for the experimental treatment of fatty liver disease.
Motino O, Lambertucci F, Joseph A, Durand S, Anagnostopoulos G, Li S Cell Death Differ. 2024; 32(3):434-446.
PMID: 39550516 PMC: 11894144. DOI: 10.1038/s41418-024-01410-6.
Nucleoside Diphosphate Kinases Are ATP-Regulated Carriers of Short-Chain Acyl-CoAs.
Iuso D, Guilliaumet J, Schlattner U, Khochbin S Int J Mol Sci. 2024; 25(14).
PMID: 39062771 PMC: 11277454. DOI: 10.3390/ijms25147528.
Acyl-coenzyme A binding protein MoAcb1 regulates conidiation and pathogenicity in .
Cao N, Zhu X, Bao J, Zhu L, Liu H, Lin F Front Microbiol. 2023; 14:1179536.
PMID: 37187543 PMC: 10175604. DOI: 10.3389/fmicb.2023.1179536.
Ling J, Li L, Lin L, Xie H, Zheng Y, Wan X Front Genet. 2023; 13:1057160.
PMID: 36704331 PMC: 9871394. DOI: 10.3389/fgene.2022.1057160.
Dual Role of ACBD6 in the Acylation Remodeling of Lipids and Proteins.
Soupene E, Kuypers F Biomolecules. 2022; 12(12).
PMID: 36551154 PMC: 9775454. DOI: 10.3390/biom12121726.